Cytosorbents Corporation (CTSO)
Filters blood to remove harmful toxins and inflammatory substances during critical illness and surgery.
$0.37+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-57.4%
The outlook
CTSO is trading near its 52-week lows and well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst sentiment leans bearish overall, though the average price target sits roughly 677% above the current price, suggesting a wide gap between current valuation and analyst expectations. The stock remains thinly valued at $0.37, reflecting significant uncertainty.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +677% vs current price
Analyst price target
~12-month · 2 analysts$2.88average target+677.0% vs now
Now $0.37
Low $0.75High $5.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$23.3M
52-wk high
$1.22
52-wk low
$0.35
50-day avg
$0.43
200-day avg
$0.63
Trailing P/E
—